Product Information
GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.0876 per ML under NDC 00121106716. Its NADAC has been published 35 times since Feb 4, 2026.
FDA first approved this application on Dec 3, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
250 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121106716
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA211330FDA Approved
12/3/2019
TE Code
AA
On Market Since
6/12/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 35 times since Feb 4, 2026, and over the history we have for it it has risen 4.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0876 per ML |
|---|---|
| All-time high | $0.0887 (Sep 16, 2026) |
| All-time low | $0.0825 (Jun 17, 2026) |
| 52-week high | $0.0887 |
| 52-week low | $0.0825 |
| Median price | $0.0853 |
| Average price | $0.0855 |
| Largest weekly change | +4.3% (Jul 22, 2026) |
| Weeks tracked | 35 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Gabapentin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by PAI Holdings LLC, is $0.0876 per ML (NDC 00121106716), effective Sep 30, 2026.
How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has risen 4.0%. It has been tracked across 35 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?
Since Feb 4, 2026, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0825 (Jun 17, 2026) to a high of $0.0887 (Sep 16, 2026), with a median of $0.0853 per ML.
Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 250 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 250 MG/5 ML SOLN?
GABAPENTIN 250 MG/5 ML SOLN (NDC 00121106716) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.